AI-Driven Innovations for Quality Control and Standardization: Future Strategies in Adipose-Derived Stem Cell Manufacturing
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27052388 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Riccardo Foti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Plastic and Reconstructive Surgery, Department of Surgical Sciences, Tor Vergata University, 00133 Rome, Italy. Hauptthemen laut MEDLINE: Artificial Intelligence, Adipose Tissue, Stem Cells. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Rome "Tor vergata", University of Rome- Tor Vergata “Bando di Ricerca Scientifica di Ateneo”.
Abstract (Originalsprache)
Artificial intelligence (AI), including machine learning (ML) and deep learning (DL), is increasingly transforming the study, manufacturing, and clinical translation of adipose-derived stem/stromal cells (ADSCs). ADSC-based therapies face persistent challenges related to donor variability, heterogeneous cell populations, limited standardization of culture protocols, and the need for robust quality control (QC) and potency assessment under Good Manufacturing Practice (GMP) conditions. This review discusses how AI-driven approaches can support the ADSC pipeline from donor and tissue pre-screening, through isolation and expansion, to differentiation and batch release decisions. We highlight major methodological advances in computer vision and label-free imaging for monitoring morphology, confluency, proliferation, senescence, and contamination, as well as AI-assisted optimization strategies for culture parameters and differentiation protocols. In addition, we examine the growing role of multi-omics integration (transcriptomics, proteomics, metabolomics, and secretomics) combined with ML to predict functional potency, stratify donors, and identify biomarkers associated with therapeutic efficacy. Finally, we address current limitations, including data scarcity, inter-laboratory variability, model interpretability, and regulatory requirements, and outline future perspectives such as closed-loop bioprocess control, foundation models, and federated learning frameworks. Overall, AI offers a powerful toolkit to improve the reproducibility, safety, and scalability of ADSC manufacturing and to accelerate the development of standardized, data-driven regenerative medicine products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Plastic and Reconstructive Surgery, Department of Surgical Sciences, Tor Vergata University, 00133 Rome, Italy.
- PhD Program in Applied Medical Surgical Sciences, Department of Surgical Sciences, University of Rome, 00133 Roma, Italy.
- Division of Rheumatology, AOU Policlinico "G. Rodolico" San Marco, 95121 Catania, Italy.
- PhD programme Innovative Technologies in Biomedical Sciences, University of Enna "Kore", 94100 Enna, Italy.
- Plastic Reconstructive and Aesthetic Surgery Clinic, University Hospital of Padua, 35128 Padua, Italy.
- Department of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
ORCID-Profile: Riccardo Foti, Gabriele Storti, Marco Palmesano, Roberta Foti, Guido Ciprandi, Maria Giovanna Scioli, Augusto Orlandi
Förderung
- University of Rome "Tor vergata"
- University of Rome- Tor Vergata “Bando di Ricerca Scientifica di Ateneo”
Zitieren
APA
Foti, R., Storti, G., Palmesano, M., Calicchia, A., Foti, R., Ciprandi, G., Cervelli, G., Scioli, M. G., Orlandi, A., & Cervelli, V. (2026). AI-Driven Innovations for Quality Control and Standardization: Future Strategies in Adipose-Derived Stem Cell Manufacturing. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27052388
Vancouver
Foti R, Storti G, Palmesano M, Calicchia A, Foti R, Ciprandi G, et al. AI-Driven Innovations for Quality Control and Standardization: Future Strategies in Adipose-Derived Stem Cell Manufacturing. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27052388
BibTeX
@article{Foti2026,
author = {Foti, Riccardo and Storti, Gabriele and Palmesano, Marco and Calicchia, Alessio and Foti, Roberta and Ciprandi, Guido and Cervelli, Giulio and Scioli, Maria Giovanna and Orlandi, Augusto and Cervelli, Valerio},
title = {AI-Driven Innovations for Quality Control and Standardization: Future Strategies in Adipose-Derived Stem Cell Manufacturing},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27052388}
}
EUVIMED